Zobrazeno 1 - 10
of 119
pro vyhledávání: '"A. Vermersch-Langlin"'
Autor:
Céline Phan, Nathalie Beneton, Juliette Delaunay, Ziad Reguiai, Claire Boulard, Anne-Claire Fougerousse, Elisa Cinotti, Marco Romanelli, Laure Mery-Bossard, Domitille Thomas-Beaulieu, Josiane Parier, François Maccari, Jean-Luc Perrot, Mireille Ruer-Mulard, Marie Bastien, Edouard Begon, Mahtab Samimi, Caroline Jacobzone, Nathalie Quiles-Tsimaratos, Vincent Descamps, Maud Steff, Paul Bilan, Annie Vermersch-Langlin, Mathilde Kemula, Emmanuelle Amazan, Ingrid Kupfer-Bessaguet, Anne-Caroline Cottencin, Francesca Prignano, Bulai Livideanu, Jeremy Gottlieb, Alain Beauchet, Emmanuel Mahé
Publikováno v:
Acta Dermato-Venereologica, Vol 100, Iss 18, p adv00316 (2020)
Anti-interleukin-17 agents have recently been developed for the treatment of psoriasis. This study evaluated the tolerance and effectiveness of anti-interleukin-17 agents for psoriasis in elderly patients in daily practice. A multicentre, retrospecti
Externí odkaz:
https://doaj.org/article/7a398feddaad430dba5a4a56efd6b03c
Autor:
Adrien Sanchez, Constance Mayslich, Isabelle Malet, Philippe Alain Grange, Michel Janier, Julie Saule, Pervenche Martinet, Jean-Luc Robert, Dominique Moulene, François Truchetet, Anne-Lise Pinault, Annie Vermersch-Langlin, Nadjet Benhaddou, Johan Chanal, Nicolas Dupin
Publikováno v:
Acta Dermato-Venereologica, Vol 100, Iss 14, p adv00221 (2020)
Benzathine penicillin G (BPG) is the reference treatment for early syphilis, but shortages have recently been reported, highlighting a need for the validation of alternative treatments. The aim of this study was to evaluate the genomic resistance of
Externí odkaz:
https://doaj.org/article/cf1f760b62e14452bf22ddf313e43254
Publikováno v:
In Annales de dermatologie et de venereologie November 2016 143(11):713-715
Publikováno v:
Annales de Dermatologie et de Vénéréologie. 147:667-671
Summary Introduction Ixekizumab is a recently developed biopharmaceutical used since 2016 in the US and Europe for the treatment of plaque psoriasis. Few adverse effects have been reported in the literature and ixekizumab is not known to increase the
Autor:
E. Mahé, S. Marc, C. Grodner, B. Solyga, J. Delaunay, A. Beauchet, M. Kemula, Nicolas Kluger, J.-L. Perrot, Anne-Claire Fougerousse, C. Jacobzone, J. Parier, Céline Girard, P. Bilan, C. Boulard, H. Barthelemy, M. Ruer-Mulard, D. Bouilly-Auvray, H. Aubert, Nathalie Beneton, M. Steff, Guillaume Chaby, L. Mery-Bossard, François Maccari, A.‐L. Liégeon, D. Pourchot, A. Vermersch-Langlin, Ab. Duval-Modeste, N. Quiles-Tsimaratos, D. Thomas-Beaulieu
Publikováno v:
Journal of the European Academy of Dermatology and Venereology. 34:888-896
Background Tattooing is a widespread phenomenon, with an estimated prevalence of 10-30% in Western populations. For psoriasis patients, current recommendations are to avoid having a tattoo if the disease is active and they are receiving immunosuppres
Autor:
E. Massip, P. Marcant, G. Font, S. Faiz, S. Duvert‐Lehembre, I. Alcaraz, A. Vermersch‐Langlin, M. Véron, C. Macaire, K. Faure, F. Vuotto, D. Staumont‐Sallé, F. Dezoteux
Publikováno v:
Journal of the European Academy of Dermatology and Venereology. 36
Publikováno v:
Annales de Dermatologie et de Vénéréologie. 146:265-272
Background The prevalence of psoriasis among patients presenting human immunodeficiency virus (HIV)infection is the same as in the general population, but the disease is more severe and refractory, and management is more complex. The aim of this surv
Publikováno v:
In Annales de dermatologie et de venereologie November 2016 143(11):716-717
Autor:
Jean-Luc Robert, Christiane Bébéar, Nicolas Dupin, Arabella Touati, Julie Saule, Sonia Burrel, A. Vermersch-Langlin, Dominique Moulene, Nadjet Benhaddou, Pervenche Martinet, Philippe Grange, Aude Jary, Michel Janier, C. Isnard, David Boutolleau
Publikováno v:
J Clin Microbiol
We evaluated the utility of the commercial Allplex genital ulcer real-time PCR multiplex assay for detecting Treponema pallidum, herpes simplex virus 1 (HSV-1) and 2 (HSV-2), and Chlamydia trachomatis serovar L (lymphogranuloma venereum [LGV]) DNA in
Autor:
Phan, C., Beneton, N., Delaunay, J., Reguiai, Z., Boulard, C., Fougerousse, A. -C., Cinotti, E., Romanelli, M., Mery-Bossard, L., Thomas-Beaulieu, D., Parier, J., Maccari, F., Chaby, G., Bastien, M., Begon, E., Samimi, M., Prignano, F., Beauchet, A., Mahe, E., Perrot, J. -L., Ruer-Mulard, M., Jacobzone, C., Quiles-Tsimaratos, N., Descamps, V., Steff, M., Bilan, P., Vermersch-Langlin, A., Kemula, M., Amazan, E., Kupfer-Bessaguet, I., Cottencin, A. -C., Livideanu, B., Gottlieb, J.
Apremilast is a drug recently developed for psoriasis. Few data are available on its use in the elderly. We evaluated the tolerance and effectiveness of apremilast used in daily practice for psoriasis treatment in older patients. We performed a multi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a33d79c6d63d96a5232cd2bd9bc5ec0f
http://hdl.handle.net/11365/1132008
http://hdl.handle.net/11365/1132008